Skip to content
Untitled design (2)
  • Solutions
    • OPRA Central Monitoring
    • OPRA Risk Assessment & Management
    • E-learning
    • Frequently Asked Questions
  • About
    • About
    • Events
    • Careers – we’re hiring!
  • RBQM Resources
    • Complimentary Training
    • RBQM Guides
    • Industry News
    • #5M5Q Interviews
    • TRI Blog
  • Contact

Blog

What is ICH E6 R3
Blog, News

Why ICH E6 R3 Matters for Clinical Trials

July 30, 2025 Rachel Penn

Explore how E6 (R3) reshapes trial design, oversight, and culture, and why the industry must be ready to respond.

What is ICH E6 R3
Blog, News

What is ICH E6 (R3)?

July 24, 2025 Rachel Penn

ICH E6 (R3) sets a new global benchmark for Good Clinical Practice, modernizing oversight with principle-based, risk-driven, and digitally enabled trial design.

Blog, News

Lessons from London

May 16, 2025 Jo Hall

This blog explores how clinical research leaders are navigating post-Covid uncertainty, shifting buyer expectations, and the growing need for authenticity, trust, and AI-driven value.

Posts pagination

Previous 1 2 3

Search

Categories

  • Blog (23)
  • Decentralized Trials (3)
  • Events (6)
  • FDA Guidance (5)
  • News (46)
  • Press Release (3)
  • SCDM (2)

Recent posts

  • When RBQM Pilots Stall-1
    When RBQM Pilots Stall
  • The Non-Negotiable Standard in Clinical Trials-1
    The Non-Negotiable Standard in Clinical Trials
  • How Much Change Is Enough to Be Compliant-1
    How Much Change Is Enough to Be Compliant with ICH E6(R3)?
NEWSLETTER

Subscribe to The Quality Issue

Want the latest RBQM updates sent straight to your inbox? subscribe to our newsletter.


    • Cookie Policy
    • Privacy policy
    • Contact
    • LinkedIn
    • TRI blog
    • 1 Signet Court, Swanns Road, Cambridge, CB5 8LA, UK
    • 0044 1223 660 511
    • info@tritrials.com
    Solutions
    • Risk Assessment
    • Centralized Monitoring
    Resources
    • Free Training
    • Industry News
    Company
    • About
    • Events
    • News
    • Careers

    ©Triumph Research Intelligence Limited. All Rights Reserved.